New study explores next-generation vaccine technology for RSV
Calder Biosciences, Inc., a next-generation vaccine company, has published an article that debuts and validates the application of Calder's '3D Vaxlock' platform technology. When applied to the Respiratory Syncytial Virus ...
Mar 14, 2024
0
1